Trial Profile
Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2014
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Clopidogrel; Itraconazole
- Indications Embolism and thrombosis; HIV-1 infections
- Focus Biomarker; Pharmacokinetics
- 05 Nov 2010 New trial record.